Home › Cancro della vescica non muscolo-invasivo › New York

Studi clinici su Cancro della vescica non muscolo-invasivo nello stato di New York

16 studi su Cancro della vescica non muscolo-invasivo cercano partecipanti presso sedi nello stato di New York.

Città nello stato di New York

Testo ufficiale dello studio (inglese)

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

Icahn School of Medicine at Mount Sinai, New York
Weill Cornell Medical Center, New York

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ott 2026 · NCT06503614

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
e altri 3

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07000084

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06833073

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Icahn School of Medicine at Mount Sinai (ISMMS) - Mount Sinai Queens - Infusion Center, Astoria
NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center - Sidney Kimmel Center for Prostate and Urologic Cancers, New York
e altri 3

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT06995677

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

Associated Medical Professionals, Syracuse

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT06919965

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

MSK Commack, Commack
MSK Westchester, Harrison
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
e altri 9

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07206225

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

SUNY Upstate Med Univ, Syracuse

In reclutamentoStudio osservazionale

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07309445

A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

Roswell Park Comprehensive Cancer Center, Buffalo

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT06733363

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
University of Rochester, Department of Urology, Rochester
Associated Medical Professionals of NY, PLLC, Syracuse
e altri 1

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

New York University (NYU), New York
Weill Cornell Medicine, New York
Icahn School of Medicine at Mount Sinai, New York
e altri 4

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT05614739

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Memorial Sloan Kettering Suffolk - Commack (Consent Only), Commack
Memorial Sloan Kettering Westchester (Consent Only), East White Plains
Columbia University (Data Collection Only), New York
e altri 2

In reclutamentoFase 3

Età 21 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT06929286

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
e altri 1

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 14 ago 2026 · NCT05126472

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Albany Medical College, Albany
Roswell Park Cancer Institute, Buffalo
Mount Sinai Medical Center, New Haven
e altri 1

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 7 ago 2026 · NCT04752722

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

SUNY Upstate Medical University, Syracuse

In reclutamentoFase 1/2

Età da 18 a 85 · Tutti i sessi · Aggiornato il 27 mar 2026 · NCT06800963

Blue Light Cystoscopy With Cysview® Registry

NYU Langone's Perlmutter Cancer Center, New York

In reclutamentoStudio osservazionale

Età 18 e oltre · Tutti i sessi · Aggiornato il 18 dic 2025 · NCT02660645

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Site 02-015 - Associated Medical Professionals of New York, Syracuse

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 24 nov 2025 · NCT03945162

Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.